{"id":"https://openalex.org/W2188961358","doi":null,"title":"Effective Pharmacologic Management of","display_name":"Effective Pharmacologic Management of","publication_year":2007,"publication_date":"2007-01-01","ids":{"openalex":"https://openalex.org/W2188961358","mag":"2188961358"},"language":"en","primary_location":{"id":"mag:2188961358","doi":null,"is_oa":false,"landing_page_url":"https://www.iqanda-cme.com/assets/pdf/Farlow3.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071364728","display_name":"Martin Rhys Farlow","orcid":"https://orcid.org/0000-0001-7897-5471","observed_orcids":["https://orcid.org/0000-0001-7897-5471"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Martin R. Farlow","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7897-5471","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5060487287","display_name":"Jeffrey L. Cummings","orcid":"https://orcid.org/0000-0001-8944-4158","observed_orcids":["https://orcid.org/0000-0001-8944-4158"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeffrey L. Cummings","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8944-4158","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.24922647,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.763700008392334,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.763700008392334,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.13779999315738678,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.09000000357627869,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9980000257492065},{"id":"https://openalex.org/keywords/pharmacological-management","display_name":"pharmacological management","score":0.8830000162124634},{"id":"https://openalex.org/keywords/cholinesterase-inhibitors","display_name":"cholinesterase inhibitors","score":0.9599999785423279},{"id":"https://openalex.org/keywords/rivastigmine","display_name":"rivastigmine","score":0.9620000123977661},{"id":"https://openalex.org/keywords/donepezil","display_name":"donepezil","score":1.0},{"id":"https://openalex.org/keywords/galantamine","display_name":"galantamine","score":1.0},{"id":"https://openalex.org/keywords/memantine","display_name":"memantine","score":0.9959999918937683},{"id":"https://openalex.org/keywords/nmda-receptor-antagonist","display_name":"NMDA receptor antagonists","score":0.8809999823570251},{"id":"https://openalex.org/keywords/early-diagnosis","display_name":"early diagnosis","score":0.7490000128746033},{"id":"https://openalex.org/keywords/treatment-algorithm","display_name":"treatment algorithm","score":0.7559999823570251},{"id":"https://openalex.org/keywords/cognitive-decline","display_name":"cognitive decline","score":0.8960000276565552},{"id":"https://openalex.org/keywords/functional-decline","display_name":"functional decline","score":0.9290000200271606},{"id":"https://openalex.org/keywords/treatment-monitoring","display_name":"treatment monitoring","score":0.41999998688697815}],"concepts":[{"id":"https://openalex.org/C2776332859","wikidata":"https://www.wikidata.org/wiki/Q411887","display_name":"Rivastigmine","level":5,"score":0.9662951231002808},{"id":"https://openalex.org/C2779056891","wikidata":"https://www.wikidata.org/wiki/Q412690","display_name":"Galantamine","level":5,"score":0.958147406578064},{"id":"https://openalex.org/C2780904820","wikidata":"https://www.wikidata.org/wiki/Q415081","display_name":"Donepezil","level":4,"score":0.9542651176452637},{"id":"https://openalex.org/C2779484449","wikidata":"https://www.wikidata.org/wiki/Q412189","display_name":"Memantine","level":4,"score":0.8489936590194702},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6049731373786926},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5869494676589966},{"id":"https://openalex.org/C502032728","wikidata":"https://www.wikidata.org/wiki/Q11081","display_name":"Alzheimer's disease","level":3,"score":0.572413980960846},{"id":"https://openalex.org/C31896038","wikidata":"https://www.wikidata.org/wiki/Q415635","display_name":"Cholinesterase","level":2,"score":0.5445298552513123},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.48445916175842285},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.46421197056770325},{"id":"https://openalex.org/C2778122271","wikidata":"https://www.wikidata.org/wiki/Q410943","display_name":"Receptor antagonist","level":4,"score":0.4192420244216919},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3959568738937378},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.37362515926361084},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3137960731983185},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.2904745042324066},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.13093429803848267},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2188961358","doi":null,"is_oa":false,"landing_page_url":"https://www.iqanda-cme.com/assets/pdf/Farlow3.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":65,"referenced_works":["https://openalex.org/W60328733","https://openalex.org/W1164896577","https://openalex.org/W1589659473","https://openalex.org/W1847168837","https://openalex.org/W1854455018","https://openalex.org/W1893036398","https://openalex.org/W1930672392","https://openalex.org/W1941528024","https://openalex.org/W1954961492","https://openalex.org/W1962254068","https://openalex.org/W1967779348","https://openalex.org/W1971352874","https://openalex.org/W1971797932","https://openalex.org/W1972294144","https://openalex.org/W1984404080","https://openalex.org/W1985528178","https://openalex.org/W1990020776","https://openalex.org/W1995006760","https://openalex.org/W1997886955","https://openalex.org/W2003106226","https://openalex.org/W2015449679","https://openalex.org/W2019720355","https://openalex.org/W2024214628","https://openalex.org/W2030079540","https://openalex.org/W2031709382","https://openalex.org/W2034963833","https://openalex.org/W2037468903","https://openalex.org/W2039595489","https://openalex.org/W2041689445","https://openalex.org/W2045535066","https://openalex.org/W2047095305","https://openalex.org/W2047511834","https://openalex.org/W2051697442","https://openalex.org/W2051776695","https://openalex.org/W2056034609","https://openalex.org/W2057679568","https://openalex.org/W2064887457","https://openalex.org/W2081285591","https://openalex.org/W2085870059","https://openalex.org/W2092356280","https://openalex.org/W2099532845","https://openalex.org/W2105121811","https://openalex.org/W2107327698","https://openalex.org/W2107820540","https://openalex.org/W2115294836","https://openalex.org/W2117134611","https://openalex.org/W2118391051","https://openalex.org/W2122692162","https://openalex.org/W2124568421","https://openalex.org/W2128136330","https://openalex.org/W2128529067","https://openalex.org/W2129809216","https://openalex.org/W2132806643","https://openalex.org/W2135897934","https://openalex.org/W2137777161","https://openalex.org/W2141237892","https://openalex.org/W2151918054","https://openalex.org/W2159011576","https://openalex.org/W2162134510","https://openalex.org/W2166070786","https://openalex.org/W2275901170","https://openalex.org/W2326200998","https://openalex.org/W2419560600","https://openalex.org/W2912402341","https://openalex.org/W3216169949"],"related_works":["https://openalex.org/W2007654265","https://openalex.org/W4240668771","https://openalex.org/W2905362366","https://openalex.org/W2083074012","https://openalex.org/W2399737119","https://openalex.org/W1660356340","https://openalex.org/W1996054288","https://openalex.org/W138736586","https://openalex.org/W7135823008","https://openalex.org/W4281621935"],"abstract_inverted_index":{"In":[0],"order":[1],"to":[2,37],"assist":[3],"physicians":[4],"in":[5,42,96,112],"the":[6,19,52,74],"effective":[7],"pharmacologic":[8,15,146],"management":[9,56],"of":[10,22,45,60,67,76,161],"this":[11],"challenging":[12],"population,":[13],"evidence-based":[14],"treatment":[16],"algorithms":[17],"for":[18,40,118,127],"different":[20,43],"stages":[21,44],"Alzheimer\u2019s":[23,46,61,100,122,131],"disease":[24],"have":[25],"been":[26],"developed.":[27],"Evidence-based":[28],"guidelines":[29],"outlining":[30],"pharmacotherapeutic":[31],"strategies":[32],"can":[33],"be":[34,107,140,150],"systematically":[35],"implemented":[36],"optimize":[38],"outcomes":[39],"patients":[41,97,119,128],"disease.":[47,101,132],"The":[48,102],"first":[49],"step":[50],"toward":[51],"best":[53],"possible":[54],"long-term":[55],"is":[57,90],"early":[58,65],"diagnosis":[59],"disease,":[62,123],"thereby":[63],"facilitating":[64],"initiation":[66],"cholinesterase":[68,116],"inhibitor":[69,83,117],"treatment,":[70,134],"which":[71],"may":[72,106],"stabilize/reduce":[73],"rate":[75],"symptomatic":[77],"cognitive":[78,135],"and":[79,124,136,145,159],"functional":[80,137],"decline.":[81],"Cholinesterase":[82],"therapy":[84,95,147],"with":[85,98,114,120,129],"rivastigmine,":[86],"donepezil,":[87],"or":[88,111],"galantamine":[89],"endorsed":[91],"as":[92,109,125],"standard":[93],"first-line":[94],"mild-to-moderate":[99],"N-methyl-D-aspartate":[103],"receptor-antagonist,":[104],"memantine,":[105],"used":[108],"monotherapy":[110,126],"combination":[113],"a":[115],"moderate":[121],"severe":[130],"During":[133],"status":[138],"should":[139,148],"monitored":[141],"over":[142],"6-month":[143],"intervals,":[144],"ideally":[149],"continued":[151],"until":[152],"there":[153],"are":[154],"no":[155],"meaningful":[156],"social":[157],"interactions":[158],"quality":[160],"life":[162],"has":[163],"irreversibly":[164],"deteriorated.":[165],"\u00a9":[166],"2007":[167]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}